Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.

How to buy Genesis Healthcare stock | 0.5

Own Genesis Healthcare stock in just a few minutes.

Posted

Fact checked

Genesis Healthcare, Inc is a medical care facilities business based in the US. Genesis Healthcare shares (GEN) are listed on the NYSE and all prices are listed in US Dollars. Genesis Healthcare employs 55,000 staff and has a trailing 12-month revenue of around USD$4.3 billion.

How to buy shares in Genesis Healthcare

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Genesis Healthcare. Find the stock by name or ticker symbol: GEN. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Genesis Healthcare reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$0.5, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Genesis Healthcare, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Genesis Healthcare. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Genesis Healthcare's share price?

Since the stock market crash in March caused by coronavirus, Genesis Healthcare's share price has had significant negative movement.

Its last market close was USD$0.5, which is 71.10% down on its pre-crash value of USD$1.73 and 46.00% down on the lowest point reached during the March crash when the shares fell as low as USD$0.73.

If you had bought USD$1,000 worth of Genesis Healthcare shares at the start of February 2020, those shares would have been worth USD$569.54 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$331.13.

Genesis Healthcare share price

Use our graph to track the performance of GEN stocks over time.

Genesis Healthcare shares at a glance

Information last updated 2020-10-14.
Latest market closeUSD$0.5
52-week rangeUSD$0.5 - USD$1.86
50-day moving average USD$0.6026
200-day moving average USD$0.7474
Wall St. target priceUSD$1.38
PE ratio 1.5
Dividend yield N/A (0%)
Earnings per share (TTM) USD$0.245

Compare trading platforms

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Sofi Invest
$0
Stocks
N/A
0%
A free way to invest in stocks, ETFs and crypto.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
Tastyworks
$0
Stocks, Options, ETFs, Futures
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
0%
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Genesis Healthcare stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Genesis Healthcare price performance over time

Historical closes compared with the close of $0.5 from 2020-10-19

1 week (2020-10-19) -0.79%
1 month (2020-09-25) -14.09%
3 months (2020-07-24) -37.24%
6 months (2020-04-24) -36.31%
1 year (2019-10-25) -63.77%
2 years (2018-10-26) -65.28%
3 years (2017-10-26) -51.46%
5 years (2015-10-26) -90.14%

Is Genesis Healthcare under- or over-valued?

Valuing Genesis Healthcare stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Genesis Healthcare's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Genesis Healthcare's P/E ratio

Genesis Healthcare's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 2x. In other words, Genesis Healthcare shares trade at around 2x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Genesis Healthcare's EBITDA

Genesis Healthcare's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$160.9 million.

The EBITDA is a measure of a Genesis Healthcare's overall financial performance and is widely used to measure a its profitability.

Genesis Healthcare financials

Revenue TTM USD$4.3 billion
Gross profit TTM USD$2.1 billion
Return on assets TTM -1.75%
Return on equity TTM 0%
Profit margin 1.07%
Book value $-7.36
Market capitalisation USD$99.6 million

TTM: trailing 12 months

Shorting Genesis Healthcare shares

There are currently 947,502 Genesis Healthcare shares held short by investors – that's known as Genesis Healthcare's "short interest". This figure is 49.1% down from 1.9 million last month.

There are a few different ways that this level of interest in shorting Genesis Healthcare shares can be evaluated.

Genesis Healthcare's "short interest ratio" (SIR)

Genesis Healthcare's "short interest ratio" (SIR) is the quantity of Genesis Healthcare shares currently shorted divided by the average quantity of Genesis Healthcare shares traded daily (recently around 577745.12195122). Genesis Healthcare's SIR currently stands at 1.64. In other words for every 100,000 Genesis Healthcare shares traded daily on the market, roughly 1640 shares are currently held short.

However Genesis Healthcare's short interest can also be evaluated against the total number of Genesis Healthcare shares, or, against the total number of tradable Genesis Healthcare shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Genesis Healthcare's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Genesis Healthcare shares in existence, roughly 10 shares are currently held short) or 0.0121% of the tradable shares (for every 100,000 tradable Genesis Healthcare shares, roughly 12 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Genesis Healthcare.

Find out more about how you can short Genesis Healthcare stock.

Genesis Healthcare share dividends

We're not expecting Genesis Healthcare to pay a dividend over the next 12 months.

Have Genesis Healthcare's shares ever split?

Genesis Healthcare's shares were split on a 10:11 basis on 4 April 2013. So if you had owned 11 shares the day before before the split, the next day you'd have owned 10 shares. This wouldn't directly have changed the overall worth of your Genesis Healthcare shares – just the quantity. However, indirectly, the new 10% higher share price could have impacted the market appetite for Genesis Healthcare shares which in turn could have impacted Genesis Healthcare's share price.

Genesis Healthcare share price volatility

Over the last 12 months, Genesis Healthcare's shares have ranged in value from as little as $0.5 up to $1.86. A popular way to gauge a stock's volatility is its "beta".

GEN.US volatility(beta: 1.45)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Genesis Healthcare's is 1.4501. This would suggest that Genesis Healthcare's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Genesis Healthcare overview

Genesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services; Rehabilitation Therapy Services; and Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy. In addition, the company offers other specialty medical services, such as physician, staffing, and other healthcare related services. As of April 23, 2020, it provided inpatient services through a network of approximately 400 skilled nursing facilities and assisted/senior living communities in 25 states; and supplied rehabilitation and respiratory therapy to approximately 1,200 healthcare locations in 44 states, the District of Columbia and China. The company was formerly known as FC-GEN Operations Investment, LLC and changed its name to Genesis HealthCare, Inc. in February 2015. Genesis HealthCare, Inc. was founded in 2003 and is headquartered in Kennett Square, Pennsylvania.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site